Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Prospective testing of a neurophysiologic biomarker for treatment decisions in major depressive disorder: The PRISE-MD trial.
Journal: Journal of psychiatric research
Published: August 06, 2019
Sleep loss activates cellular inflammation and signal transducer and activator of transcription (STAT) family proteins in humans.
Journal: Brain, behavior, and immunity
Published: July 14, 2014
The Antidepressant Treatment Response Index as a Predictor of Reboxetine Treatment Outcome in Major Depressive Disorder.
Journal: Clinical EEG and neuroscience
Published: August 02, 2013
Showing 1-3 of 3
Last Updated: 09/26/2026